Glimepiride, Metformin, and Rosiglitazone are used in the treatment of type 2 diabetes mellitus.
How Glimepiride, Metformin, and Rosiglitazone Work Glimepiride, Metformin, and Rosiglitazone is a combination of three antidiabetic medications: Glimepiride, Metformin, and Rosiglitazone. They work through different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea that increases the amount of insulin released by the pancreas to lower blood glucose levels. Metformin is a biguanide that reduces glucose production in the liver, delays glucose absorption from the intestines, and increases the body's sensitivity to insulin. Rosiglitazone is a thiazolidinedione that further enhances insulin sensitivity.
Common side effects of Glimepiride, Metformin, and Rosiglitazone include hypoglycemia (low blood glucose level), nausea, taste changes, diarrhea, stomach pain, headache, edema (swelling), weight gain, blurred vision, bone fractures, and respiratory tract infections.
Glimepiride 2mg + Metformin 500mg + Rosiglitazone 2mg

MRP ₹60.5
Glimepiride 2mg + Metformin 500mg + Rosiglitazone 15mg

₹95
Glimepiride 2mg + Metformin 500mg + Rosiglitazone 2mg

₹56.7
Glimepiride 2mg + Metformin 500mg + Rosiglitazone 2mg

₹64.8